T1	Participants 46 64	endometrial cancer
T2	Participants 526 601	467 women with type 1 or 2 endometrial cancer and 582 age-matched controls.
T3	Participants 675 772	tumor specimens of 46 women with type 1 endometrial cancer enrolled in RTOG trials 9708 and 9905.
T4	Participants 1319 1370	for patients with the variant and wild-type alleles
